Reuters logo
8 months ago
BRIEF-Alcon receives U.S. FDA approval for acrysof iq restor +3.0d multifocal toric intraocular lens
December 22, 2016 / 11:19 PM / 8 months ago

BRIEF-Alcon receives U.S. FDA approval for acrysof iq restor +3.0d multifocal toric intraocular lens

Dec 22 (Reuters) - Novartis Ag :

* Alcon - U.S. commercialization expected to start on a rolling basis in Q1 of 2017 for acrysof iq restor

* Alcon receives U.S. FDA approval for acrysof iq restor +3.0d multifocal toric intraocular lens for cataract patients Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below